LifeStance Health Group, Inc.
LFST
$8.10
$0.172.14%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.57% | 5.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.57% | 5.05% | |||
| Cost of Revenue | 4.55% | 3.51% | |||
| Gross Profit | 7.63% | 8.33% | |||
| SG&A Expenses | 5.81% | -0.99% | |||
| Depreciation & Amortization | -0.86% | -0.91% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.68% | 2.13% | |||
| Operating Income | 23.47% | 147.04% | |||
| Income Before Tax | 29.97% | 232.52% | |||
| Income Tax Expenses | 56.07% | 1.14% | |||
| Earnings from Continuing Operations | 22.07% | 983.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 22.07% | 983.38% | |||
| EBIT | 23.47% | 147.04% | |||
| EBITDA | 13.11% | 51.03% | |||
| EPS Basic | 22.26% | 975.00% | |||
| Normalized Basic EPS | 33.74% | 236.99% | |||
| EPS Diluted | 24.75% | 953.57% | |||
| Normalized Diluted EPS | 34.58% | 233.33% | |||
| Average Basic Shares Outstanding | 0.07% | 0.01% | |||
| Average Diluted Shares Outstanding | -0.23% | 1.83% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||